Pacira | PCRX - Market Capitalization

Stock Price
22.42
Daily Change
-0.22 -0.97%
Monthly
-9.96%
Yearly
-14.26%
Q2 Forecast
22.18

Pacira reported $1.05B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Astellas Pharma JPY 4.56T 770.92B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Coherus Biosciences USD 172M 19M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Novo Nordisk A/S DKK 1.45T 421.31B May/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.58B 265M May/2026
Pfizer USD 147.4B 6.42B May/2026
Supernus Pharmaceuticals USD 2.82B 155M May/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zoetis USD 39.98B 9.73B May/2026